Kenneth C. Anderson Livres

Focused on Multiple Myeloma, this issue features contributions from leading experts, including Dr. Kenneth C. Anderson. It covers a range of topics such as the nuances of Monoclonal Gammopathy, diagnostic strategies, and risk stratification. Treatment discussions encompass newly diagnosed patients eligible and ineligible for transplants, as well as strategies for relapsed or refractory cases. Additionally, it explores maintenance therapy, novel targeted and immune-based therapies, and the role of allotransplantation, along with insights on Waldenstrom's Macroglobulinemia.

Richardson and Anderson, both teachers of medicine at Harvard Medical School, compile novel therapies being developed to target specific molecular pathways involved in the oncogenesis of myeloma. Chapters cover epidemiology and molecular pathogenesis, mechanisms of drug resistance, thalidomide treatment, bone disease, high-dose chemotherapy, supportive care, and novel biological therapies. The book will be of interest to specialist hematologists and oncologists and other healthcare providers. Annotation ©2004 Book News, Inc., Portland, OR (booknews.com)